Simvastatin 80 mg

DRUG4 trials

Sponsors

University of Illinois at Chicago, Johns Hopkins University, Heidelberg University, NeuroBo Pharmaceuticals Inc.

Conditions

Aneurysmal Subarachnoid HemorrhageCerebral VasospasmHypercholesterolemiaInflammationIntracerebral HemorrhageType 2 Diabetes

Phase 1

Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy Volunteers

CompletedNCT02587390

NeuroBo Pharmaceuticals Inc.Hypercholesterolemia

Start: 2000-05-31End: 2000-07-31Updated: 2020-04-09

Phase 2

Simvastatin For Intracerebral Hemorrhage Study

TerminatedNCT00718328

Johns Hopkins UniversityIntracerebral Hemorrhage

Start: 2008-10-31End: 2009-06-30Updated: 2017-10-09

Unknown Phase

Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage

TerminatedNCT00487461

University of Illinois at ChicagoAneurysmal Subarachnoid Hemorrhage, Cerebral Vasospasm

Start: 2007-05-31End: 2009-06-30Updated: 2015-11-25

Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe

CompletedNCT01424891

Heidelberg UniversityInflammation, Type 2 Diabetes

Start: 2004-04-30End: 2011-08-31Updated: 2011-08-29